Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo.

导出原文传递

翻译打印收藏纠错

作者： Marcell,Baranyi ^[1] ; Dominika,Rittler ^[1] ; Eszter,Molnár ^[1] ; Senji,Shirasawa ^[2] ; István,Jalsovszky ^[3] ; Imre Károly,Varga ^[3] ; Luca,Hegedűs ^[4] ; Afrodíté,Németh ^[5] ; Magdolna,Dank ^[5] ; Clemens,Aigner ^[4] ; József,Tóvári ^[6] ; József,Tímár ^[1] ; Balázs,Hegedűs ^[7] ; Tamás,Garay ^[8]

作者单位： 2nd Department of Pathology, Semmelweis University, Budapest, H-1091, Hungary. ^[1] Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. ^[2] Faculty of Science, Institute of Chemistry, Department of Organic Chemistry, Eötvös Loránd University, Budapest, H-1117, Hungary. ^[3] Department of Thoracic Surgery, Ruhrlandklinik, University Duisburg-Essen, D-45239, Essen, Germany. ^[4] Oncology Center, Semmelweis University, Budapest, H-1091, Hungary. ^[5] Department of Experimental Pharmacology, National Institute of Oncology, Budapest, H-1122, Hungary. ^[6] 2nd Department of Pathology, Semmelweis University, Budapest, H-1091, Hungary. balazs.hegedues@rlk.uk-essen.de. ^[7] Department of Thoracic Surgery, Ruhrlandklinik, University Duisburg-Essen, D-45239, Essen, Germany. balazs.hegedues@rlk.uk-essen.de. ^[8] Pázmány Péter Catholic University Faculty of Information Technology and Bionics, Budapest, H-1083, Hungary. ^[9] HAS Postdoctoral Fellowship Program Hungarian Academy of Sciences, Budapest, H-1051, Hungary. ^[10]

关键词 Colorectal cancer In vitro In vivo Lipophilic bisphosphonate Zoledronic acid